155 related articles for article (PubMed ID: 15242997)
1. Inhibiting MMP activity prevents the development of endometriosis in the chicken chorioallantoic membrane model.
Nap AW; Dunselman GA; de Goeij AF; Evers JL; Groothuis PG
Hum Reprod; 2004 Oct; 19(10):2180-7. PubMed ID: 15242997
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinase messenger RNA expression in human endometriosis grafts cultured on a chicken chorioallantoic membrane.
Juhasz-Böss I; Hofele A; Lattrich C; Buchholz S; Ortmann O; Malik E
Fertil Steril; 2010 Jun; 94(1):40-5. PubMed ID: 19345347
[TBL] [Abstract][Full Text] [Related]
3. The role of matrix metalloproteinases in the pathogenesis of endometriosis.
Pitsos M; Kanakas N
Reprod Sci; 2009 Aug; 16(8):717-26. PubMed ID: 19351962
[TBL] [Abstract][Full Text] [Related]
4. Expression of membrane-type 5 matrix metalloproteinase in human endometrium and endometriosis.
Gaetje R; Holtrich U; Engels K; Kourtis K; Cikrit E; Kissler S; Rody A; Karn T; Kaufmann M
Gynecol Endocrinol; 2007 Oct; 23(10):567-73. PubMed ID: 17952761
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives prevent the development of endometriosis in the chicken chorioallantoic membrane model.
Nap AW; Groothuis PG; Punyadeera C; Klein-Hitpass L; Kamps R; Delvoux B; Dunselman GA
Contraception; 2008 Sep; 78(3):257-65. PubMed ID: 18692618
[TBL] [Abstract][Full Text] [Related]
6. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer.
Braundmeier AG; Nowak RA
Am J Reprod Immunol; 2006 Sep; 56(3):201-14. PubMed ID: 16911716
[TBL] [Abstract][Full Text] [Related]
7. [Matrix metalloproteinases and their role in menstruation and endometriosis].
Hudelist G; Singer CF; Keckstein J
Zentralbl Gynakol; 2005 Oct; 127(5):320-4. PubMed ID: 16195977
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium.
Shaco-Levy R; Sharabi S; Benharroch D; Piura B; Sion-Vardy N
Eur J Obstet Gynecol Reprod Biol; 2008 Aug; 139(2):226-32. PubMed ID: 18295959
[TBL] [Abstract][Full Text] [Related]
9. [Expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in ectopic and eutopic endometrium].
Chen QH; Qu JY; Xu YY; Qiu NX; Zhuang YZ; Zhong S; Fang QQ
Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):809-12. PubMed ID: 15733405
[TBL] [Abstract][Full Text] [Related]
10. Curcumin delays endometriosis development by inhibiting MMP-2 activity.
Jana S; Rudra DS; Paul S; Snehasikta S
Indian J Biochem Biophys; 2012 Oct; 49(5):342-8. PubMed ID: 23259320
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases.
Gueders MM; Foidart JM; Noel A; Cataldo DD
Eur J Pharmacol; 2006 Mar; 533(1-3):133-44. PubMed ID: 16487964
[TBL] [Abstract][Full Text] [Related]
12. Localization of matrix metalloproteinases, (MMPs) their tissue inhibitors, and vascular endothelial growth factor (VEGF) in growth plates of children and adolescents indicates a role for MMPs in human postnatal growth and skeletal maturation.
Haeusler G; Walter I; Helmreich M; Egerbacher M
Calcif Tissue Int; 2005 May; 76(5):326-35. PubMed ID: 15868281
[TBL] [Abstract][Full Text] [Related]
13. Interleukin 1alpha and tissue-lytic matrix metalloproteinase-1 are elevated in ectopic endometrium of patients with endometriosis.
Hudelist G; Lass H; Keckstein J; Walter I; Wieser F; Wenzl R; Mueller R; Czerwenka K; Kubista E; Singer CF
Hum Reprod; 2005 Jun; 20(6):1695-701. PubMed ID: 15746198
[TBL] [Abstract][Full Text] [Related]
14. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
15. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-13 and membrane type-1 matrix metalloproteinase in peritoneal fluid of women with endometriosis.
Laudanski P; Szamatowicz J; Ramel P
Gynecol Endocrinol; 2005 Aug; 21(2):106-10. PubMed ID: 16109597
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinases and endometriosis.
Osteen KG; Yeaman GR; Bruner-Tran KL
Semin Reprod Med; 2003 May; 21(2):155-64. PubMed ID: 12917785
[TBL] [Abstract][Full Text] [Related]
18. Regulation of matrix metalloproteinases activity studied in human endometrium as a paradigm of cyclic tissue breakdown and regeneration.
Gaide Chevronnay HP; Selvais C; Emonard H; Galant C; Marbaix E; Henriet P
Biochim Biophys Acta; 2012 Jan; 1824(1):146-56. PubMed ID: 21982799
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-27 is expressed in CD163+/CD206+ M2 macrophages in the cycling human endometrium and in superficial endometriotic lesions.
Cominelli A; Gaide Chevronnay HP; Lemoine P; Courtoy PJ; Marbaix E; Henriet P
Mol Hum Reprod; 2014 Aug; 20(8):767-75. PubMed ID: 24810263
[TBL] [Abstract][Full Text] [Related]
20. Membrane-type matrix metalloproteinases and vascularization in human endometrium during the menstrual cycle.
Plaisier M; Koolwijk P; Hanemaaijer R; Verwey RA; van der Weiden RM; Risse EK; Jungerius C; Helmerhorst FM; van Hinsbergh VW
Mol Hum Reprod; 2006 Jan; 12(1):11-8. PubMed ID: 16415334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
